SEC Form 4 · accession 0001209191-17-030369
INTEGRA LIFESCIENCES HOLDINGS CORP · IART
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James M Sullivan
Director
Period of report
May 4, 2017
Accepted (ET)
May 5, 2017 · 4:50 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000917520
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 4, 2017 | M | 15,658 | $10.74 | A | 70,154 | D | |
| Common StockF1 | May 4, 2017 | S | 15,658 | $45.8918 | D | 54,496 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F3,F2 | $10.74 | May 4, 2017 | M | 15,658 | D | — | May 20, 2017 | Common Stock | 15,658 | 0 | D |
Explanation of responses
- F1The price shown above represents the weighted average price of the shares sold. The range of sale prices was $45.83 to $45.97.
- F225% of the stock options vest every quarter from the grant date of 05/20/2009.
- F3This stock option was previously reported as covering 7,829 shares of common stock at an exercise price of $21.48 per share. In accordance with the terms of the stock option plan, the exercise price of the option and number of shares subject to the option have been adjusted to reflect the two-for-one stock split that occurred on December 21, 2016.